NEW YORK (GenomeWeb News) – Testing the expression of a specific set of genes early in breast cancer therapy can predict which seemingly low-risk tumors are destined to become high risk — and help guide treatment accordingly, new research suggests.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.